|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, Ward E and Thun MJ:
Cancer occurrence. Methods Mol Biol. 471:3–29. 2009. View Article : Google Scholar
|
|
3
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li XJ, Leem SH, Park MH and Kim SM:
Regulation of YAP through an Akt-dependent process by 3,
3′-diindolylmethane in human colon cancer cells. Int J Oncol.
43:1992–1998. 2013.PubMed/NCBI
|
|
5
|
Cho KH, Park S, Lee KS, Jang SI, Yoo KB,
Kim JH and Park EC: A single measure of cancer burden in Korea from
1999 to 2010. Asian Pac J Cancer Prev. 14:5249–5255. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park JH, Lee KS and Choi KS: Burden of
cancer in Korea during 2000–2020. Cancer Epidemiol. 37:353–359.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huguet EL, McMahon JA, McMahon AP,
Bicknell R and Harris AL: Differential expression of human Wnt
genes 2, 3, 4, and 7B in human breast cell lines and normal and
disease states of human breast tissue. Cancer Res. 54:2615–2621.
1994.PubMed/NCBI
|
|
8
|
Weber-Hall SJ, Phippard DJ, Niemeyer CC
and Dale TC: Developmental and hormonal regulation of Wnt gene
expression in the mouse mammary gland. Differentiation. 57:205–214.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moon RT and Miller JR: The APC tumor
suppressor protein in development and cancer. Trends Genet.
13:256–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takahashi M, Fukuda K, Sugimura T and
Wakabayashi K: Beta-catenin is frequently mutated and demonstrates
altered cellular location in azoxymethane-induced rat colon tumors.
Cancer Res. 58:42–46. 1998.PubMed/NCBI
|
|
11
|
Bienz M and Clevers H: Linking colorectal
cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luu HH, Zhang R, Haydon RC, Rayburn E,
Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, et al:
Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Curr Cancer Drug Targets. 4:653–671. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mishra L, Shetty K, Tang Y, Stuart A and
Byers SW: The role of TGF-beta and Wnt signaling in
gastrointestinal stem cells and cancer. Oncogene. 24:5775–5789.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li XJ, Park ES, Park MH and Kim SM:
3,3′-Diindolylmethane suppresses the growth of gastric cancer cells
via activation of the Hippo signaling pathway. Oncol Rep.
30:2419–2426. 2013.PubMed/NCBI
|
|
15
|
Kim SJ, Lee JS and Kim SM:
3,3′-Diindolylmethane suppresses growth of human esophageal
squamous cancer cells by G1 cell cycle arrest. Oncol Rep.
27:1669–1673. 2012.PubMed/NCBI
|
|
16
|
Rahman KM, Li Y and Sarkar FH:
Inactivation of akt and NF-kappaB play important roles during
indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr
Cancer. 48:84–94. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong C, Kim HA, Firestone GL and Bjeldanes
LF: 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in
human breast cancer cells that is accompanied by Sp1-mediated
activation of p21(WAF1/CIP1) expression. Carcinogenesis.
23:1297–1305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hong C, Firestone GL and Bjeldanes LF:
Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane
(DIM) in human breast cancer cells. Biochem Pharmacol.
63:1085–1097. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Banerjee S, Kong D, Wang Z, Bao B, Hillman
GG and Sarkar FH: Attenuation of multi-targeted
proliferation-linked signaling by 3,3′-diindolylmethane (DIM): From
bench to clinic. Mutat Res. 728:47–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ye S, Lee KB, Park MH, Lee JS and Kim SM:
p63 regulates growth of esophageal squamous carcinoma cells via the
Akt signaling pathway. Int J Oncol. 44:2153–2159. 2014.PubMed/NCBI
|
|
21
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligo-nucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SM, Park YY, Park ES, Cho JY, Izzo JG,
Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, et al: Prognostic
biomarkers for esophageal adenocarcinoma identified by analysis of
tumor transcriptome. PLoS One. 5:e150742010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin H, Park MH and Kim SM:
3,3′-Diindolylmethane potentiates paclitaxel-induced antitumor
effects on gastric cancer cells through the Akt/FOXM1 signaling
cascade. Oncol Rep. 33:2031–2036. 2015.PubMed/NCBI
|
|
25
|
Kim M, Kim M, Lee S, Kuninaka S, Saya H,
Lee H, Lee S and Lim DS: cAMP/PKA signalling reinforces the
LATS-YAP pathway to fully suppress YAP in response to actin
cytoskeletal changes. EMBO J. 32:1543–1555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cho JY, Lim JY, Cheong JH, Park YY, Yoon
SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression
signature-based prognostic risk score in gastric cancer. Clin
Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heagerty PJ and Zheng Y: Survival model
predictive accuracy and ROC curves. Biometrics. 61:92–105. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim SM, Leem SH, Chu IS, Park YY, Kim SC,
Kim SB, Park ES, Lim JY, Heo J, Kim YJ, et al: Sixty-five
gene-based risk score classifier predicts overall survival in
hepatocellular carcinoma. Hepatology. 55:1443–1452. 2012.
View Article : Google Scholar
|
|
29
|
Nicastro HL, Firestone GL and Bjeldanes
LF: 3,3′-diindolyl-methane rapidly and selectively inhibits
hepatocyte growth factor/c-Met signaling in breast cancer cells. J
Nutr Biochem. 24:1882–1888. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen C, Chen SM, Xu B, Chen Z, Wang F, Ren
J, Xu Y, Wang Y, Xiao BK and Tao ZZ: In vivo and in vitro study on
the role of 3,3′-diindolylmethane in treatment and prevention of
nasopharyngeal carcinoma. Carcinogenesis. 34:1815–1821. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ahmad A, Ali S, Ahmed A, Ali AS, Raz A,
Sakr WA and Rahman KM: 3, 3′-Diindolylmethane enhances the
effectiveness of herceptin against HER-2/neu-expressing breast
cancer cells. PLoS One. 8:e546572013. View Article : Google Scholar
|
|
32
|
Li Y, Kong D, Ahmad A, Bao B and Sarkar
FH: Targeting bone remodeling by isoflavone and
3,3′-diindolylmethane in the context of prostate cancer bone
metastasis. PLoS One. 7:e330112012. View Article : Google Scholar
|
|
33
|
Gao N, Cheng S, Budhraja A, Liu EH, Chen
J, Chen D, Yang Z, Luo J, Shi X and Zhang Z: 3,3′-Diindolylmethane
exhibits anti-leukemic activity in vitro and in vivo through an
Akt-dependent process. PLoS One. 7:e317832012. View Article : Google Scholar
|
|
34
|
Weng JR, Bai LY, Chiu CF, Wang YC and Tsai
MH: The dietary phytochemical 3,3′-diindolylmethane induces G2/M
arrest and apoptosis in oral squamous cell carcinoma by modulating
Akt-NF-κB, MAPK, and p53 signaling. Chem Biol Interact.
195:224–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Li X and Guo B: Chemopreventive
agent 3,3′-diindolyl-methane selectively induces proteasomal
degradation of class I histone deacetylases. Cancer Res.
70:646–654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Choi HJ, Lim Y and Park JH: Induction of
G1 and G2/M cell cycle arrests by the dietary compound
3,3′-diindolylmethane in HT-29 human colon cancer cells. BMC
Gastroenterol. 9:392009. View Article : Google Scholar
|
|
37
|
Bhatnagar N, Li X, Chen Y, Zhou X, Garrett
SH and Guo B: 3,3′-diindolylmethane enhances the efficacy of
butyrate in colon cancer prevention through down-regulation of
survivin. Cancer Prev Res (Phila). 2:581–589. 2009. View Article : Google Scholar
|
|
38
|
Rahman KW, Li Y, Wang Z, Sarkar SH and
Sarkar FH: Gene expression profiling revealed survivin as a target
of 3,3′-diindolylmethane-induced cell growth inhibition and
apoptosis in breast cancer cells. Cancer Res. 66:4952–4960. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
